Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,677Revenue $M378Net Margin (%)5.5Z-Score15.3
Enterprise Value $M1,486EPS $0.6Operating Margin %7.3F-Score4
P/E(ttm))107Cash Flow Per Share $2.9Pre-tax Margin (%)6.6Higher ROA y-yN
Price/Book3.410-y EBITDA Growth Rate %0Quick Ratio5.0Cash flow > EarningsY
Price/Sales3.85-y EBITDA Growth Rate %13.2Current Ratio5.9Lower Leverage y-yY
Price/Cash Flow11.4y-y EBITDA Growth Rate %-49.3ROA % (ttm)3.7Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)4.2Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M28.3ROI % (ttm)6.2Gross Margin Increase y-yN

Gurus Latest Trades with ARTC

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ARTCJohn Paulson 2014-06-30 Sold Out -0.47%$48.13 - $48.63
($48.48)
$ 48.590%Sold Out0
ARTCMario Gabelli 2014-06-30 Sold Out -0.12%$48.13 - $48.63
($48.48)
$ 48.590%Sold Out0
ARTCJohn Paulson 2014-03-31 Buy 0.47%$39.32 - $49.56
($47.19)
$ 48.593%New holding, 2000000 sh.2,000,000
ARTCMario Gabelli 2014-03-31 Add0.04%$39.32 - $49.56
($47.19)
$ 48.593%Add 43.15%465,656
ARTCJoel Greenblatt 2013-12-31 Sold Out -0.11%$34.49 - $40.03
($37.02)
$ 48.5931%Sold Out0
ARTCJoel Greenblatt 2013-09-30 Add0.09%$31.67 - $37.37
($34.89)
$ 48.5939%Add 407.67%98,823
ARTCJoel Greenblatt 2013-06-30 Reduce-0.03%$33.03 - $36.19
($34.39)
$ 48.5941%Reduce -48.93%19,466
ARTCJoel Greenblatt 2013-03-31 Add0.03%$34.59 - $36.88
($35.82)
$ 48.5936%Add 96.91%38,119
ARTCJoel Greenblatt 2012-12-31 Reduce-0.04%$29.73 - $34.09
($32.36)
$ 48.5950%Reduce -47.09%19,359
ARTCJoel Greenblatt 2012-09-30 Reduce-0.08%$27.35 - $32.4
($29.74)
$ 48.5963%Reduce -50.25%36,588
ARTCGeorge Soros 2012-09-30 Sold Out -0.02%$27.35 - $32.4
($29.74)
$ 48.5963%Sold Out0
ARTCJoel Greenblatt 2012-03-31 Add0.06%$24.74 - $32.52
($26.36)
$ 48.5984%Add 58.88%72,128
ARTCGeorge Soros 2012-03-31 Reduce-0.03%$24.74 - $32.52
($26.36)
$ 48.5984%Reduce -31.46%50,000
ARTCJoel Greenblatt 2011-12-31 Add0.03%$25.56 - $31.84
($29.28)
$ 48.5966%Add 24.38%45,398
ARTCJoel Greenblatt 2011-09-30 Add0.09%$27.98 - $34.77
($31.71)
$ 48.5953%Add 101.04%36,498
ARTCGeorge Soros 2011-09-30 Reduce-0.03%$27.98 - $34.77
($31.71)
$ 48.5953%Reduce -45.16%77,052
ARTCJohn Hussman 2011-06-30 Sold Out $32.31 - $35.33
($33.57)
$ 48.5945%Sold Out0
ARTCJoel Greenblatt 2011-03-31 Buy 0.17%$27.82 - $35.27
($31.35)
$ 48.5955%New holding, 16645 sh.16,645
ARTCGeorge Soros 2011-03-31 Buy 0.06%$27.82 - $35.27
($31.35)
$ 48.5955%New holding, 141304 sh.141,304
ARTCJohn Hussman 2011-03-31 Reduce-0.27%$27.82 - $35.27
($31.35)
$ 48.5955%Reduce -51.18%476,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ARTC is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
ARTC Mario Gabelli 2014-06-30000Sold Out
ARTC John Paulson 2014-06-30000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


ARTC: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
PROTHRO BRUCEChief Regulatory Officer & SVP 2014-02-03Sell3,474$48.590view
WOLOSZKO JEANChief Tech Officer & SVP R&D 2014-01-09Sell32,627$45.676.39view
PROTHRO BRUCEChief Regulatory Officer & SVP 2014-01-08Sell33,478$45.826.05view
BOYAN BARBARA DDirector 2014-01-08Sell10,000$457.98view
PROTHRO BRUCEChief Regulatory Officer & SVP 2014-01-06Sell6,167$39.7522.24view
WOLOSZKO JEANChief Technology Officer & SVP 2013-12-19Sell10,657$39.9821.54view
BOYAN BARBARA DDirector 2013-12-19Sell10,000$4021.48view
PACEK JAMES LSr VP,Global Markets & Sales 2013-12-16Sell2,949$3924.59view
WOLOSZKO JEANChief Technology Officer & SVP 2013-10-30Sell1,342$37.9528.04view
FOSTER JAMESDirector 2013-10-07Sell2,500$34.4840.92view

Press Releases about ARTC :

    Quarterly/Annual Reports about ARTC:

    News about ARTC:

    Articles On GuruFocus.com
    Morning Coffee: Real-Time Picks May 30 2014 
    Mario Gabelli Comments on ArthroCare Corp Apr 30 2014 
    Steven Cohen Significantly Increases in ArthroCare Corp., Almost 300% Dec 03 2012 
    Weekly CFO Buys Highlight: CYTR, API, CLGX, PLBC, ARTC Mar 05 2012 
    Stryker Corp. (SYK) Dividend Stock Analysis Dec 16 2011 
    Weekly CFO Buys Highlight: FCTOA, GNBT, CTTC, ELGX, ARTC Nov 06 2010 
    Comment for Fair Value Calculation Using Discounted Cash Flow Model Dec 08 2009 
    Guru Stocks at 52-Week Low: Genzyme Corp, ArthroCare Corp, Ticketmaster. Nov 30 2008 

    More From Other Websites
    ArthroCare Ex-Chief Baker Gets 20-Year Term for Fraud Aug 29 2014
    Health device firm's ex-execs convicted of fraud Jun 03 2014
    Health device firm's ex-execs convicted of fraud Jun 03 2014
    ARTHROCARE CORP Files SEC form 8-K, Other Events May 29 2014
    ArthroCare, Smith & Nephew to close merger no later than May 29 May 21 2014
    ARTHROCARE CORP Files SEC form 8-K, Other Events May 21 2014
    ARTHROCARE CORP Financials May 09 2014
    ArthroCare Q1 Earnings Miss Ests; Revs In Line May 09 2014
    ARTHROCARE CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders May 08 2014
    Factbox: M&A frenzy in healthcare sector May 06 2014
    M&A frenzy in healthcare sector May 06 2014
    ArthroCare Reports First Quarter 2014 Financial Results May 02 2014
    ARTHROCARE CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial... May 02 2014
    Smith & Nephew to Pay $12 Million to End Investor Suits Apr 10 2014
    ARTHROCARE CORP Files SEC form 8-K, Other Events Apr 10 2014
    M&A and IPOs a Theme for Medical Device Sector in 2014 Mar 24 2014
    Continued Improvement in Medical Device End Markets for 2014: A Wall Street Transcript Interview... Mar 24 2014
    Wall Street Transcript Interview with Gregory J. Fluet, the CEO of Urologix, Inc. (ULGX) Mar 17 2014
    ARTHROCARE CORP Files SEC form 8-K, Other Events Mar 14 2014
    U.S./Canada daily earnings hits & misses Feb 13 - 1800 ET Feb 13 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK